Literature DB >> 8450227

Involvement of IFN-gamma and transforming growth factor-beta in graft-vs-host reaction-associated immunosuppression.

R Huchet1, M Bruley-Rosset, C Mathiot, D Grandjon, O Halle-Pannenko.   

Abstract

The mechanisms of the suppressive activity of spleen cells from mice undergoing a graft-vs-host reaction (GVH) to non-H-2 histocompatibility Ag were investigated. In our model GVH is induced by injecting bone marrow and spleen cells from B10.D2 (H-2d Mlsb) donors into lethally irradiated (DBA/2 x B10.D2)F1 (H-2d/d Mlsa/b) recipients that differ only with regard to non-H-2 Ag. GVH spleen cells inhibit the mitogenic responses to Con A and LPS, as well as the anti-bromelain-treated mouse RBC (Br-MRBC) antibody response. This suppression was nonspecific and non-H-2-restricted and was not modified after treatment with anti-Thy-1 plus C. Conversely it was abrogated after treatment with L-leucyl methyl ester. These features permitted the identification of non-T cell, L-leucyl methyl ester-sensitive, cells involved in this type of suppression. The suppression mediated by GVH spleen cells was linked to the activity of IFN-gamma and transforming growth factor-beta 1 (TGF-beta 1) (TGF-beta 1 was found to be synthesized by GVH spleen T cells). mAb to IFN-gamma abrogated the suppression of the mitogenic response to Con A and the anti-Br-MRBC response and slightly reversed the suppression of the mitogenic response to LPS. Anti-TGF-beta 1 antibody partially abrogated the suppression of the mitogenic response to LPS and totally abrogated that of the anti-Br-MRBC response but left unmodified the suppression of the mitogenic response to Con A. These results are discussed within the framework of the mechanisms underlying the immunosuppression associated with GVH.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450227

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  In vitro simulation of immunosuppression caused by Trypanosoma brucei: active involvement of gamma interferon and tumor necrosis factor in the pathway of suppression.

Authors:  A Darji; A Beschin; M Sileghem; H Heremans; L Brys; P De Baetselier
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

2.  Inhibition of T cell responses by activated human CD8+ T cells is mediated by interferon-gamma and is defective in chronic progressive multiple sclerosis.

Authors:  K E Balashov; S J Khoury; D A Hafler; H L Weiner
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

3.  Mast cells display natural suppressor activity partially by releasing transforming growth factor-beta.

Authors:  Z Q Hu; T Yamazaki; Z Cai; T Yoshida; T Shimamura
Journal:  Immunology       Date:  1994-07       Impact factor: 7.397

Review 4.  Graft-versus-host disease and the Th1/Th2 paradigm.

Authors:  W Krenger; J L Ferrara
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

5.  Phenotypic analysis of pulmonary perivascular mononuclear infiltrates that occur as a direct result of acute lethal graft-versus-host disease describes the onset of interstitial pneumonitis.

Authors:  D L Workman; J Clancy
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

6.  A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.

Authors:  M Falcone; B Yeung; L Tucker; E Rodriguez; N Sarvetnick
Journal:  J Exp Med       Date:  1999-10-04       Impact factor: 14.307

Review 7.  Biologic functions of the IFN-gamma receptors.

Authors:  G Tau; P Rothman
Journal:  Allergy       Date:  1999-12       Impact factor: 13.146

8.  The IL-10 and IFN-gamma pathways are essential to the potent immunosuppressive activity of cultured CD8+ NKT-like cells.

Authors:  Li Zhou; Hongjie Wang; Xing Zhong; Yulan Jin; Qing-Sheng Mi; Ashok Sharma; Richard A McIndoe; Nikhil Garge; Robert Podolsky; Jin-Xiong She
Journal:  Genome Biol       Date:  2008-07-29       Impact factor: 13.583

9.  Alteration of intracerebral cytokine production in mice infected with herpes simplex virus types 1 and 2.

Authors:  G Lewandowski; M V Hobbs; F E Bloom
Journal:  J Neuroimmunol       Date:  1994-11       Impact factor: 3.478

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.